LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SU11274 | 3.33 | uM | LJP5 | 3 | J08 | 72 | hr | 658 | 3330 | 3938 | 0.8455 | 0.8741 |
Hs 578T | SU11274 | 10 | uM | LJP5 | 1 | J07 | 72 | hr | 658 | 961 | 3908 | 0.2459 | 0.1587 |
Hs 578T | SU11274 | 10 | uM | LJP5 | 2 | J07 | 72 | hr | 658 | 965 | 3953 | 0.2441 | 0.1594 |
Hs 578T | SU11274 | 10 | uM | LJP5 | 3 | J07 | 72 | hr | 658 | 974 | 3938 | 0.2473 | 0.1640 |
Hs 578T | Canertinib | 0.04 | uM | LJP6 | 1 | H12 | 72 | hr | 658 | 3892 | 3705 | 1.0502 | 1.0397 |
Hs 578T | Canertinib | 0.04 | uM | LJP6 | 2 | H12 | 72 | hr | 658 | 3891 | 3807 | 1.0219 | 1.0172 |
Hs 578T | Canertinib | 0.04 | uM | LJP6 | 3 | H12 | 72 | hr | 658 | 3931 | 3769 | 1.0428 | 1.0336 |
Hs 578T | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 658 | 3875 | 3705 | 1.0456 | 1.0361 |
Hs 578T | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 658 | 3984 | 3807 | 1.0463 | 1.0361 |
Hs 578T | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 658 | 3824 | 3769 | 1.0144 | 1.0114 |
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 658 | 3757 | 3705 | 1.0138 | 1.0110 |
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 658 | 3791 | 3807 | 0.9957 | 0.9966 |
Hs 578T | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 658 | 3581 | 3769 | 0.9499 | 0.9596 |
Hs 578T | Canertinib | 1.11 | uM | LJP6 | 1 | H09 | 72 | hr | 658 | 3512 | 3705 | 0.9477 | 0.9574 |
Hs 578T | Canertinib | 1.11 | uM | LJP6 | 2 | H09 | 72 | hr | 658 | 3571 | 3807 | 0.9379 | 0.9500 |
Hs 578T | Canertinib | 1.11 | uM | LJP6 | 3 | H09 | 72 | hr | 658 | 3565 | 3769 | 0.9457 | 0.9561 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 1 | H08 | 72 | hr | 658 | 2982 | 3705 | 0.8047 | 0.8331 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 2 | H08 | 72 | hr | 658 | 3245 | 3807 | 0.8523 | 0.8776 |
Hs 578T | Canertinib | 3.33 | uM | LJP6 | 3 | H08 | 72 | hr | 658 | 3070 | 3769 | 0.8144 | 0.8434 |
Hs 578T | Canertinib | 10 | uM | LJP6 | 1 | H07 | 72 | hr | 658 | 332 | 3705 | 0.0896 | -0.2400 |
Hs 578T | Canertinib | 10 | uM | LJP6 | 2 | H07 | 72 | hr | 658 | 394 | 3807 | 0.1035 | -0.1834 |
Hs 578T | Canertinib | 10 | uM | LJP6 | 3 | H07 | 72 | hr | 658 | 328 | 3769 | 0.0870 | -0.2417 |
Hs 578T | NVP-AEW541 | 0.04 | uM | LJP5 | 1 | E18 | 72 | hr | 658 | 4082 | 3908 | 1.0444 | 1.0341 |
Hs 578T | NVP-AEW541 | 0.04 | uM | LJP5 | 2 | E18 | 72 | hr | 658 | 3935 | 3953 | 0.9953 | 0.9963 |
Hs 578T | NVP-AEW541 | 0.04 | uM | LJP5 | 3 | E18 | 72 | hr | 658 | 3900 | 3938 | 0.9902 | 0.9924 |